By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > Proton pump inhibitor > Pantoprazole

Pantoprazole

GMJ
Last updated: 02/06/2026 14:30
By
Prof. Giorgi Pkhakadze
Share
4 Min Read
SHARE
3 min read|546 words

Pantoprazole

What is Pantoprazole?

Pantoprazole is a proton pump inhibitor (PPI) medication that reduces the amount of acid produced in the stomach. It is commonly prescribed to treat gastroesophageal reflux disease (GERD), peptic ulcers, and other conditions caused by excess stomach acid. Pantoprazole works by blocking the enzyme system responsible for acid production in the stomach lining.

Uses

Pantoprazole is approved for several gastrointestinal conditions:

  • Gastroesophageal reflux disease (GERD): Treats erosive esophagitis and maintains healing of acid-related damage to the esophagus
  • Peptic ulcer disease: Helps heal and prevent stomach and duodenal ulcers, including those caused by nonsteroidal anti-inflammatory drugs (NSAIDs)
  • Helicobacter pylori eradication: Used in combination with antibiotics to eliminate H. pylori bacteria that can cause ulcers
  • Zollinger-Ellison syndrome: Manages this rare condition where tumors cause excessive acid production
  • Stress ulcer prophylaxis: Prevents stress-related bleeding in hospitalized patients in intensive care units

How it works

Pantoprazole blocks proton pumps, which are enzymes located in the acid-producing cells of the stomach lining. By inhibiting these pumps, pantoprazole significantly reduces stomach acid production for an extended period, typically lasting 24 hours or more after a single dose. This allows damaged tissue in the esophagus and stomach to heal while preventing further acid-related injury.

Side effects

Common side effects include:

Submit Your Paper
GMJ_Submit_Banner
  • Headache
  • Diarrhea
  • Nausea and vomiting
  • Stomach pain or flatulence
  • Dizziness
  • Joint pain
  • Fatigue

Serious side effects to watch for:

  • Severe diarrhea that may indicate C. difficile infection
  • Bone fractures, particularly with long-term use
  • Low magnesium levels causing muscle spasms, irregular heartbeat, or seizures
  • Kidney problems including acute kidney injury
  • Severe skin reactions or allergic responses

Warnings and precautions

  • Long-term use risks: Extended use may increase risk of bone fractures, vitamin B12 deficiency, and low magnesium levels
  • Pregnancy considerations: Pantoprazole is classified as pregnancy category B, generally considered safe but should only be used when clearly needed
  • Liver function: Patients with severe liver disease may need dose adjustments, as pantoprazole is metabolized by the liver
  • Infection risk: Reduced stomach acid may increase susceptibility to certain intestinal infections
  • Gradual discontinuation: Stopping suddenly after long-term use may cause rebound acid production

Interactions

Pantoprazole can interact with several medications:

  • Warfarin: May increase bleeding risk by enhancing warfarin’s anticoagulant effects
  • Clopidogrel: Pantoprazole may reduce clopidogrel’s effectiveness in preventing blood clots
  • Atazanavir and rilpivirine: Reduced stomach acid decreases absorption of these HIV medications
  • Iron supplements: Decreased acid production can impair iron absorption
  • Digoxin: Pantoprazole may increase digoxin levels, potentially causing toxicity
  • Methotrexate: May increase methotrexate levels, particularly with high-dose methotrexate therapy
  • Ketoconazole and itraconazole: These antifungal medications require stomach acid for proper absorption

Check interactions with the GMJ Interaction Checker

Dosage

Typical adult dosages vary by condition:

  • GERD treatment: 40 mg once daily for 8 weeks
  • GERD maintenance: 40 mg once daily
  • Peptic ulcer disease: 40 mg once daily for 4-8 weeks
  • Zollinger-Ellison syndrome: 40 mg twice daily, adjusted based on individual response
  • H. pylori eradication: 40 mg twice daily in combination with antibiotics for 7-14 days

Pantoprazole is typically taken 30 minutes before meals. Dosage should always be determined by a healthcare provider based on individual medical conditions, response to treatment, and other medications being taken.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Pantoprazole." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/pantoprazole/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
How Coffee and Tea Reduce Iron Absorption: A Mechanism Explained

Polyphenols in coffee and tea bind non-heme iron in the gut, reducing…

Eggs and Alzheimer’s risk: New evidence from a 15-year study challenges decades of dietary caution

A 15-year study of 39,498 older adults found that eating eggs five…

Sleep loss triggers simultaneous damage across seven body systems, new evidence shows

Controlled studies show that restricting sleep to 4–6 hours per night for…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Rabeprazole

By
Prof. Giorgi Pkhakadze
02/06/2026

Lansoprazole

By
Prof. Giorgi Pkhakadze
02/06/2026

Esomeprazole

By
Prof. Giorgi Pkhakadze
02/06/2026

Omeprazole

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up